STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
By
Matthew Herper
1d agoen
Source
STATSTAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learnedstatnews.comCall AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology right now.
You might also wanna read
OpenAI and Anthropic CEOs Sign Joint Letter Warning Against AI-Assisted Bioweapons
Rival AI CEOs Sam Altman (OpenAI) and Dario Amodei (Anthropic) have signed an open letter warning against the potential misuse of AI for cre

Anthropic in talks with Samsung to co-develop new AI chip
TechBriefly·4d ago
Anthropic launches AI tool to speed up drug discovery
thechemicalengineer.com·3d ago
Anthropic Files for IPO, Escalating Competition with OpenAI
Anthropic has filed for an IPO, intensifying the competitive race with OpenAI in the AI sector. The article discusses how investors are scru
OpenAI and Anthropic CEOs clash over whether AI will eliminate or enhance white-collar jobs
The article examines the growing divide between AI labs OpenAI and Anthropic regarding the impact of AI on white-collar jobs. OpenAI's CEO S
Anthropic debuts flagship Claude Opus 4.8 AI model as IPO race with OpenAI heats up
finance.yahoo.com·1mo ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.